Top-News
Biotechnologie Kanada

Abattis Bioceuticals News

Aktie
WKN:  A1XCMU ISIN:  CA00258G1037 US-Symbol:  ATTBF
-    $
+0,00 $
0,00%
09.05.24 15:30:05
Handeln Depot/Watchlist
Aktienanzahl *
476,05 Mio.
Marktkapitalisierung *
438 €
Streubesitz
-
Index-Zugehörigkeit
-
IR-Website
zur Website
*Stand: 01.03.2022

Unternehmensmeldungen

02.03.18 - DGAP
Abattis Comments on Recent Market Activity
DGAP-News: Abattis Bioceuticals Corp. / Key word(s): Miscellaneous Abattis Comments on Recent Market Activity 02.03.2018 / 02:02 The issuer is solely responsible for the content ...
22.12.17 - DGAP
Abattis Announces Letter of Intent to Acquire Winston Resources
DGAP-News: Abattis Bioceuticals Corp. / Key word(s): Miscellaneous Abattis Announces Letter of Intent to Acquire Winston Resources 22.12.2017 / 15:28 The issuer is solely ...
06.04.17 - DGAP
Abattis Bioceuticals Gets Added to the Marijuana Index by MJIC
DGAP-News: Abattis Bioceuticals Corp. / Key word(s): Miscellaneous Abattis Bioceuticals Gets Added to the Marijuana Index by MJIC 06.04.2017 / 14:46 The issuer is solely ...
02.11.16 - DGAP
Abattis Announces the Appointment of New Independent Director
DGAP-News: Abattis Bioceuticals Corp. / Key word(s): Miscellaneous Abattis Announces the Appointment of New Independent Director 02.11.2016 / 14:47 The issuer is solely ...
24.10.16 - DGAP
Abattis Executes Memorandum of Agreement to Acquire 100% of Experion Biotechnologies Inc.
DGAP-News: Abattis Bioceuticals Corp. / Key word(s): Miscellaneous Abattis Executes Memorandum of Agreement to Acquire 100% of Experion Biotechnologies Inc. 24.10.2016 / ...
05.10.16 - DGAP
Abattis Signs MOU with Global Damon Pharma of South Korea
DGAP-News: Abattis Bioceuticals Corp. / Key word(s): Miscellaneous Abattis Signs MOU with Global Damon Pharma of South Korea 05.10.2016 / 14:30 The issuer is solely ...
03.10.16 - DGAP
Abattis' Northern Vine Labs Receives Controlled Substance Licence
DGAP-News: Abattis Bioceuticals Corp. / Key word(s): Miscellaneous Abattis' Northern Vine Labs Receives Controlled Substance Licence 03.10.2016 / 14:46 The issuer is solely ...
25.04.16 - DGAP
Abattis Names Michael Yung as Ceo
DGAP-News: Abattis Bioceuticals Corp. / Key word(s): Miscellaneous Abattis Names Michael Yung as Ceo 25.04.2016 / 14:00 The issuer is solely responsible for the content of this ...
18.04.16 - DGAP
Abattis Announces Co-Formulation with Vitagum(TM)
DGAP-News: Abattis Bioceuticals Corp. / Key word(s): Miscellaneous Abattis Announces Co-​Formulation with Vitagum(TM) 18.04.2016 / 14:00 The issuer is solely responsible for the ...
12.04.16 - DGAP
Abattis Receives NPN from Health Canada for Phyto(NOS)(TM)
DGAP-News: Abattis Bioceuticals Corp. / Key word(s): Miscellaneous Abattis Receives NPN from Health Canada for Phyto(NOS)(TM) 12.04.2016 / 14:00 The issuer is solely ...
06.04.16 - DGAP
Abattis Agrees to License Its NOXX Botanical Blends Products
DGAP-News: Abattis Bioceuticals Corp. / Key word(s): Miscellaneous Abattis Agrees to License Its NOXX Botanical Blends Products 06.04.2016 / 16:51 The issuer is solely ...
03.03.16 - DGAP
Abattis Subsidiary, Vergence, Announces First Product in Lineup Now Available for Sale
DGAP-News: Abattis Bioceuticals Corp. / Key word(s): Miscellaneous Abattis Subsidiary, Vergence, Announces First Product in Lineup Now Available for Sale 03.03.2016 / 15:00 The ...

Newssuche

Videos

newspaper
17.05.24 +14,15%
Technical Trading: Gold Long-​Chance
Gold Long Typ: Turbo Open End WKN: VD1G7Y Hebel: 10 Laufzeit: OpenEnd Einstieg: Market ... Mehr »